Skip to content
OpenCapital
Get started

Johnson & Johnson JNJ Innovative Medicine — Adjustments To Revenue Recognized, Percent

Similar metrics at other companies

Rigel Pharmaceuticals logo
RIGLDiscounts and allowances — Revenue recognized
-$20.47M-23.0%
ARD
ARDTHealth Care, Patient Service — Revenue adjustment, net
$7.5M-15.7%
McKesson logo
MCKMedical-Surgical Solutions — Other adjustments
$0-100%
Exelixis logo
EXELDiscounts and allowances — Total revenues
-$240.38M-15.3%
Voya Financial logo
VOYAInvestment Management Segment — Adjusted operating revenues
$251M+3.3%
Amneal Pharmaceuticals, Inc. logo
AMRXAffordable Medicines — Net revenue
$423.24M+2.1%

Other financials

Income statement

See full
Revenue$24.1B+9.9%
Gross profit$16.0B+9.8%
Operating income$6.3B+2.3%
Net income$5.2B-52.4%
EPS (diluted)$2.14-52.9%

Balance sheet

See full
Cash & equivalents$21.7B-43.6%
Total debt$55.0B+5.2%
Total equity$81.2B+3.9%
Total assets$200.89B+3.7%

Cash flow

See full
Operating cash flow$2.5B-39.8%
CapEx$1.0B+31.9%
Free cash flow$1.5B-56.6%

Valuation

See full
Market cap$623.71B+66.9%
Enterprise value$657.01B+61.9%
P/E29.6×+13.2×
P/S6.5×+2.3×

Profitability

See full
Gross margin67.8%-0.5pp
Operating margin26.4%+2.8pp
Net margin21.8%-2.6pp
FCF margin18.5%-4.3pp

Returns & leverage

See full
Return on equity26.4%-3.0pp
Debt / equity0.7×0.0×
Current ratio1×-0.2×

Where this comes from

Reported directly by Johnson & Johnson in its filing.

Tagged under the XBRL concept jnj:AdjustmentsToRevenueRecognizedPercent.

The official record: Johnson & Johnson’s 10-Q, filed April 22, 2026, on SEC EDGAR. View the filing →

Ask your AI about Johnson & Johnson's innovative medicine — adjustments to revenue recognized, percent.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Johnson & Johnson's innovative medicine — adjustments to revenue recognized, percent?
Johnson & Johnson (JNJ) reported innovative medicine — adjustments to revenue recognized, percent of 4.7% in Q1 2026.
What does innovative medicine — adjustments to revenue recognized, percent mean?
This metric represents the percentage impact of various adjustments, such as currency fluctuations, rebates, returns, or other accounting reconciliations, on the gross revenue recognized within the Innovative Medicine business segment. It serves as a bridge between gross sales and net revenue, highlighting the volatility and external factors affecting the segment's top-line performance. Monitoring this helps investors understand how much of the reported revenue growth is driven by operational success versus external adjustments.